DocuSign, Inc. (NASDAQ:DOCU) Position Boosted by B. Metzler seel. Sohn & Co. AG

B. Metzler seel. Sohn & Co. AG grew its stake in shares of DocuSign, Inc. (NASDAQ:DOCU - Free Report) by 72.7% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 8,677 shares of the company's stock after acquiring an additional 3,652 shares during the quarter. B. Metzler seel. Sohn & Co. AG's holdings in DocuSign were worth $780,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of DOCU. Norges Bank purchased a new stake in DocuSign in the fourth quarter valued at approximately $223,196,000. Arrowstreet Capital Limited Partnership boosted its holdings in shares of DocuSign by 201.6% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 2,158,311 shares of the company's stock valued at $194,118,000 after purchasing an additional 1,442,639 shares during the last quarter. Amundi grew its stake in shares of DocuSign by 565.8% during the 4th quarter. Amundi now owns 1,379,575 shares of the company's stock valued at $123,486,000 after buying an additional 1,172,368 shares during the period. American Century Companies Inc. increased its holdings in shares of DocuSign by 18.5% during the 4th quarter. American Century Companies Inc. now owns 5,315,459 shares of the company's stock worth $478,072,000 after buying an additional 831,611 shares during the last quarter. Finally, Bank of New York Mellon Corp raised its position in shares of DocuSign by 61.5% in the 4th quarter. Bank of New York Mellon Corp now owns 1,673,612 shares of the company's stock worth $150,525,000 after buying an additional 637,505 shares during the period. Institutional investors and hedge funds own 77.64% of the company's stock.

DocuSign Stock Performance

Shares of NASDAQ:DOCU traded up $2.06 during trading on Tuesday, hitting $74.01. The company's stock had a trading volume of 625,874 shares, compared to its average volume of 2,698,203. The company has a market capitalization of $14.99 billion, a PE ratio of 15.25, a PEG ratio of 6.94 and a beta of 1.20. DocuSign, Inc. has a fifty-two week low of $48.70 and a fifty-two week high of $107.86. The stock's 50-day moving average price is $85.61 and its two-hundred day moving average price is $82.45.

DocuSign (NASDAQ:DOCU - Get Free Report) last announced its earnings results on Thursday, March 13th. The company reported $0.86 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.84 by $0.02. The company had revenue of $776.25 million for the quarter, compared to analyst estimates of $760.94 million. DocuSign had a return on equity of 14.90% and a net margin of 34.73%. DocuSign's quarterly revenue was up 9.0% on a year-over-year basis. During the same period in the prior year, the company posted $0.76 EPS. On average, equities analysts predict that DocuSign, Inc. will post 1.17 earnings per share for the current fiscal year.

Analyst Ratings Changes

DOCU has been the subject of several research analyst reports. Citigroup upped their price target on DocuSign from $113.00 to $115.00 and gave the stock a "buy" rating in a research note on Friday, March 14th. William Blair raised shares of DocuSign from a "market perform" rating to an "outperform" rating in a research report on Monday, March 17th. JMP Securities reaffirmed a "market outperform" rating and set a $124.00 price target on shares of DocuSign in a research report on Tuesday, January 7th. Wells Fargo & Company increased their price objective on shares of DocuSign from $70.00 to $73.00 and gave the stock an "underweight" rating in a research report on Friday, March 14th. Finally, Needham & Company LLC restated a "hold" rating on shares of DocuSign in a report on Friday, March 14th. Two analysts have rated the stock with a sell rating, nine have issued a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Hold" and an average target price of $95.83.

Insider Activity at DocuSign

In other news, Director Teresa Briggs sold 534 shares of the company's stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $87.41, for a total value of $46,676.94. Following the sale, the director now owns 8,270 shares in the company, valued at approximately $722,880.70. This represents a 6.07 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Peter Solvik sold 10,000 shares of the stock in a transaction that occurred on Friday, January 10th. The stock was sold at an average price of $91.26, for a total value of $912,600.00. Following the transaction, the director now directly owns 150,253 shares in the company, valued at approximately $13,712,088.78. This represents a 6.24 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 57,851 shares of company stock valued at $4,911,319 over the last ninety days. Corporate insiders own 1.66% of the company's stock.

DocuSign Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.